Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
---|
10/16/2013 | CN103349791A Novel microporous medical hemostatic material and preparation method thereof |
10/16/2013 | CN103349766A Pharmaceutical composition for endless postpartum lochia |
10/16/2013 | CN103349743A Traditional Chinese medicine preparation for treating epistaxis |
10/16/2013 | CN103349712A Traditional Chinese medicine composition for treatment of functional uterine bleeding |
10/16/2013 | CN103349694A Medicine used for treating women postpartum diseases |
10/16/2013 | CN103349691A Preparation method of fermentation liquid for antiphlogosis and haemostasis |
10/16/2013 | CN103349685A Traditional Chinese medicine comprising radix paeoniae rubra and preparation method thereof |
10/16/2013 | CN103349669A Malic acid-containing composite dialysis preparation and preparation method thereof |
10/16/2013 | CN103349656A Valsartan capsule and preparation method thereof |
10/16/2013 | CN102847058B Pharmaceutical composition for treating urinary retention after caesarean section |
10/16/2013 | CN102727749B Medicine for treating aplastic anemia |
10/16/2013 | CN102671078B Medicine composition for curing myelofibrosis and hepatofibrosis and preparation method of medicine composition |
10/16/2013 | CN102617722B Ancylostoma caninum anticoagulant peptide, preparation and application thereof |
10/16/2013 | CN102614122B Ketorolac tromethamine nasal cavity spraying agent and preparation method thereof |
10/16/2013 | CN102488764B Preparation method for total saponins of Rubus parviflolius |
10/16/2013 | CN102451471B Polyethyleneglycol-staphylokinase conjugate as well as preparing method and application thereof |
10/16/2013 | CN102429992B Superfine powder houttuynia herb normal-temperature preparation method |
10/16/2013 | CN102379962B Traditional Chinese medicine combination for healthcare and treatment of livestock |
10/16/2013 | CN102309765B Long-acting anticoagulant polypeptide including immunoglobulin Fc segments as carriers and preparation method of same |
10/16/2013 | CN102250099B Non-peptide thrombin inhibitors as well as preparation method and medical application thereof |
10/16/2013 | CN102093285B Cyclic amide derivatives, and their production and use as antithrombotic agents |
10/16/2013 | CN102048796B Rhodiola rosea extract testing method |
10/16/2013 | CN102030709B Benzazepines compounds serving as vasopressin receptor antagonism |
10/16/2013 | CN101952249B Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives |
10/16/2013 | CN101935301B Modulators of ATP-binding cassette transporters |
10/16/2013 | CN101810862B Tanshinone IIA oral administration polymer micelle composition |
10/16/2013 | CN101605905B Method for glycosylation of flavonoid |
10/15/2013 | US8557852 Methods of using crystalline forms of a salt of a factor Xa inhibitor |
10/15/2013 | US8557785 In vivo production of small interfering RNAS that mediate gene silencing |
10/15/2013 | US8557535 Methods for preparation of platelet rich plasma |
10/15/2013 | CA2756625C Intravascular heat exchange catheter with multiple heat exchange elements such as balloons |
10/15/2013 | CA2445655C Drug releasing anastomosis devices and methods for treating anastomotic sites |
10/10/2013 | WO2013152213A1 Methods and compositions for increasing red blood cells |
10/10/2013 | WO2013150087A1 Fe(iii)-pyrazine complex compounds for treatment and prophylaxis of iron-deficiency phenomena and iron-deficiency anaemia |
10/10/2013 | WO2013149997A1 Substituted tricyclic compounds with activity towards ep1 receptors |
10/10/2013 | WO2013149996A1 Substituted tricyclic compounds with activity towards ep1 receptors |
10/10/2013 | US20130267468 Factor viii glycoforms |
10/10/2013 | US20130266553 Albumin Fusion Proteins |
10/09/2013 | EP2647697A1 Method for producing hematopoietic stem cells using pyrazole compound |
10/09/2013 | EP2647638A1 Substituted tricyclic compounds with activity towards ep1 receptors |
10/09/2013 | EP2647628A1 Substituted tricyclic compounds with activity towards ep1 receptors |
10/09/2013 | EP2647382A1 Compositions and methods for treating epithelial and retinal tissue diseases |
10/09/2013 | EP2647370A1 Transfusion preparation |
10/09/2013 | EP2646434A1 Pharmaceutical compositions, dosage forms and new forms of the compound of formula (i), and methods of use thereof |
10/09/2013 | EP2646037A1 Histone inhibition |
10/09/2013 | EP2646029A1 Treatment of jak2-mediated conditions |
10/09/2013 | EP2646007A2 Cell lines that secrete anti-angiogenic antibody-scaffolds and soluble receptors and uses thereof |
10/09/2013 | CN103342696A Substituted dihydropyrazolon for treating cardiovascular and haematological diseases |
10/09/2013 | CN103342680A Benzazepine derivatives useful as vasopressin antagonists |
10/09/2013 | CN103342679A Benzazepine derivatives useful as vasopressin antagonists |
10/09/2013 | CN103341139A Chinese medicine composition as well as preparation method and use thereof |
10/09/2013 | CN103341136A Donkey-hide gelatin oral liquid and preparation method thereof |
10/09/2013 | CN103341128A Traditional Chinese medicine composition for treating upper gastrointestinal hemorrhage and preparation method thereof |
10/09/2013 | CN103341058A Traditional Chinese medicine for treating horse ascites |
10/09/2013 | CN103341054A Traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
10/09/2013 | CN103340983A Lycium ruthenicum fruit extract as well as preparation method and application thereof |
10/09/2013 | CN103340980A Medicine for treating liver ascites and preparation method thereof |
10/09/2013 | CN103340896A Duplex dentin hypersensitivity resistant composition and application thereof |
10/09/2013 | CN103340845A 药物组合物 The pharmaceutical composition of |
10/09/2013 | CN103340844A Application of gamatine in preparing drug resisting high PTH |
10/09/2013 | CN103340839A Preparation method of earthworm fibrinolytic modified enzyme chitosan enteric microsphere capsule |
10/09/2013 | CN103340834A Clopidogrel bisulfate composition tablet and preparation method thereof |
10/09/2013 | CN103340827A Iron sucrose injection and preparation method thereof |
10/09/2013 | CN103340815A Foundation make-up for eliminating facial edema |
10/09/2013 | CN103340800A Chinese herbal medicine toothpaste and preparation method thereof |
10/09/2013 | CN103340786A Witch hazel toner |
10/09/2013 | CN103340402A Cream of peanuts, red dates and edible fungus, and preparation method and application of cream |
10/09/2013 | CN103340265A Qi-tonifying blood-nourishing lung-ventilating tea |
10/09/2013 | CN102863457B Optically-active 2- hydroxyltetrathienopyridine derivative, preparation method thereof and application of optically-active 2- hydroxyltetrathienopyridine derivative to pharmacy |
10/09/2013 | CN102727765B Internally-used medicine for treating aplastic anemia by nourishing yin and yang |
10/09/2013 | CN102727748B Traditional Chinese medicine composition for treating aplastic anemia by nourishing qi and yin |
10/09/2013 | CN102670945B Prunella vulgaris traditional Chinese medicine oral liquid for adjuvant therapy of pleurisy and preparation method thereof |
10/09/2013 | CN102670535B Clopidogrel hydrochloride tablet |
10/09/2013 | CN102657754B Thrombus collaterals-dredging medicament |
10/09/2013 | CN102652774B Drug composition for treating leukopenia and hypoimmunity caused by chemoradiotherapy and preparation method and quality detection method |
10/09/2013 | CN102641254B Preparation method of aspirin enteric-coated sustained-release preparation |
10/09/2013 | CN102210693B Method for preparing aspirin and dipyridamole multilayer tablets |
10/08/2013 | US8552062 Methods for the treatment of metabolic disorders such as diabetes |
10/08/2013 | US8552054 Anticancer agents, viricides, psychological disorders |
10/08/2013 | US8552040 Isoxazoline compounds having MIF antagonist activity |
10/08/2013 | US8551945 Methods and compositions for treating neuropathies |
10/08/2013 | CA2495048C Hemostatic compositions and devices |
10/03/2013 | WO2013148248A1 Protease-regulated antibodies |
10/03/2013 | WO2013147216A1 (2-heteroarylamino)succinic acid derivative |
10/03/2013 | WO2013147215A1 4-alkanoylamino-3-pyrazolone derivative |
10/03/2013 | WO2013147214A1 5-hydroxypyrimidine-4-carboxamide derivative |
10/03/2013 | WO2013147213A1 Anti-siglec15 antibody with modified cdr |
10/03/2013 | WO2013147117A1 Fused azole derivative |
10/03/2013 | WO2013146970A1 Novel quinoline derivative |
10/03/2013 | WO2013146969A1 Novel disubstituted cyclohexane derivative |
10/03/2013 | WO2013144860A1 A therapeutic agent for treatment of blood vessels |
10/03/2013 | WO2013143663A1 Bicyclic pyrazinone derivatives |
10/03/2013 | WO2013143466A1 Substituted pyrimidine derivative as aurora kinase inhibitor |
10/03/2013 | WO2013143462A1 Blood displacement foundation liquid and preparation method thereof |
10/03/2013 | WO2013143322A1 Method for dissolving flavonoid compound, carbon glycoside compound, or stilbene compound and method for preparing injection or powder for injection |
10/03/2013 | US20130259904 Prasugrel containing quickly released stable oral pharmaceutical compositions |
10/02/2013 | EP2644698A1 Multi-specific antigen-binding molecule having alternative function to function of blood coagulation factor viii |
10/02/2013 | EP2643016A2 Anti-il-6 antibodies for the treatment of anemia |
10/02/2013 | EP2642994A2 Use of hematopoietic growth factor mimetics |
10/02/2013 | CN103339126A Pharmaceutical compositions, dosage forms and new forms of the compound of formula (i), and methods of use thereof |